Skip to main content
Contact Us
Subscribe
E-Edition
74°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Resmed Inc
(NY:
RMD
)
184.22
+3.87 (+2.15%)
Official Closing Price
Updated: 4:10 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Resmed Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
April 18, 2024
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.
Via
Investor's Business Daily
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
April 17, 2024
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
Via
The Motley Fool
Eli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test
April 17, 2024
The results also pressured ResMed, a maker of CPAPs. CPAPs are the common treatment for sleep apnea.
Via
Investor's Business Daily
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
April 15, 2024
Via
Benzinga
Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy'
April 08, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Uber Technologies, Inc. (NYSE: UBER).
Via
Benzinga
Why NYSE:RMD qualifies as a good dividend investing stock.
April 08, 2024
Why the dividend investor may take a look at RESMED INC (NYSE:RMD).
Via
Chartmill
Expert Outlook: ResMed Through The Eyes Of 9 Analysts
March 27, 2024
Via
Benzinga
$1000 Invested In ResMed 10 Years Ago Would Be Worth This Much Today
March 28, 2024
Via
Benzinga
Peering Into ResMed's Recent Short Interest
March 26, 2024
Via
Benzinga
ASX : RMD - Resmed Stock Analysis & Elliott Wave Technical Forecast
March 21, 2024
Our Elliott Wave analysis updates the Australian Stock Exchange with Resmed Inc shares. We have identified an Expanded Flat correction pattern, indicating the potential for RMD to continue declining...
Via
Talk Markets
Why NYSE:RMD provides a good dividend, while having solid fundamentals.
March 06, 2024
Why RESMED INC (NYSE:RMD) qualifies as a good dividend investing stock.
Via
Chartmill
Got $1,000? Buy These Hot Growth Stocks Before They Take Off
February 22, 2024
If you have just $1,000 to spare, you can scoop up shares of these growth stocks before their prices explode.
Via
The Motley Fool
Uncovering Dividend Opportunities with NYSE:RMD.
February 12, 2024
Why RESMED INC (NYSE:RMD) provides a good dividend, while having solid fundamentals.
Via
Chartmill
Cracking The Code: Understanding Analyst Reviews For ResMed
January 25, 2024
Via
Benzinga
Why ResMed Stock Is Jumping Today
January 25, 2024
The medical device maker beat expectations with its latest quarterly results.
Via
The Motley Fool
Recap: ResMed Q2 Earnings
January 24, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
February 01, 2024
Via
Benzinga
ResMed Flexes Its Operating Muscle, Sends Shares Flying Above Their 200-Day Line
January 25, 2024
ResMed reported better-than-expected sales and adjusted earnings.
Via
Investor's Business Daily
AT&T To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday
January 25, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
3 Stocks to Buy to Benefit From the Booming Sleep Industry
January 23, 2024
It’s not easy to find sleep stocks to buy despite the fact the industry is booming these days from society's lack of rest and relaxation.
Via
InvestorPlace
FDA Identifies ResMed's Recall Of Certain Ventilator Device Masks With Magnets As Most Serious
January 12, 2024
ResMed (NYSE: RMD) recalls certain respiratory masks with magnets due to potential interference with medical devices. FDA Class I recall.
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
If You Invested $100 In This Stock 15 Years Ago, You Would Have $900 Today
January 10, 2024
Via
Benzinga
Demystifying ResMed: Insights From 5 Analyst Reviews
January 09, 2024
Via
Benzinga
Uncovering Dividend Opportunities with NYSE:RMD.
December 26, 2023
Why RESMED INC (NYSE:RMD) qualifies as a good dividend investing stock.
Via
Chartmill
Earnings Scheduled For January 24, 2024
January 24, 2024
Companies Reporting Before The Bell • Freeport-McMoRan (NYSE:FCX) is estimated to report quarterly earnings at $0.22 per share on revenue of $5.86 billion.
Via
Benzinga
ResMed's Earnings: A Preview
January 23, 2024
Via
Benzinga
Why NYSE:RMD provides a good dividend, while having solid fundamentals.
January 17, 2024
Exploring RESMED INC (NYSE:RMD)'s dividend characteristics.
Via
Chartmill
$1000 Invested In ResMed 15 Years Ago Would Be Worth This Much Today
December 25, 2023
Via
Benzinga
Top Picks 2024: ResMed
January 07, 2024
ResMed is the market leader in continuous positive airway pressure machines. ResMed has enjoyed a steadily growing market throughout its history, and investors have often paid sky-high valuations for...
Via
Talk Markets
(RMD) - Analyzing ResMed's Short Interest
December 22, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.